BNIP3 and breast carcinoma: Our analysis of R2 datasets revealed that BNIP3 levels are positively correlated with overall survival of patients with breast cancer treated with taxane-anthracycline (P-value = 0.035), and with Tamoxifen (P-value = 0.026) (Fig. 6c and d).